ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of newly diagnosed follicular lymphoma

Annals of Oncology

Volumn 14, Issue 8, 2003, Pages 1163-1164

  Hiddemann, W ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD20 ANTIGEN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; INTERFERON; LACTATE DEHYDROGENASE; MONOCLONAL ANTIBODY; PREDNISOLONE; PURINE DERIVATIVE; URIC ACID; VINCRISTINE;

ARTICLE; ASPIRATION BIOPSY; BLOOD ANALYSIS; BONE MARROW BIOPSY; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ECHOGRAPHY; FOLLICULAR LYMPHOMA; FOLLOW UP; HEALTH CARE ORGANIZATION; HISTOPATHOLOGY; HUMAN; LYMPH NODE BIOPSY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; STEM CELL TRANSPLANTATION; THORAX RADIOGRAPHY; THYROID FUNCTION; TREATMENT OUTCOME; TREATMENT PLANNING; WORLD HEALTH ORGANIZATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; FEMALE; HEALTH PLANNING GUIDELINES; HUMANS; LYMPHOMA, FOLLICULAR; MALE; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 0042385037     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg338     Document Type: Article

References (5)

1. MacManus PM, Hoppe RT. Is radiotherapy curative for stage I and II low grade follicular lymphoma? Results of a long term follow-up study of patients treated at Stanford University. J Clin Oncol 1996; 14: 1282-1290.
2. Stuschke M, Hoederath A, Sack H. Extended field and total central lymphatic radiotherapy for early stages nodal centroblastic-centrocytic lymphoma: results of a prospective multicenter study. Cancer 1997; 80: 2273-2284.
3. Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med 1984; 311: 1471-1475.
4. Solal-Céligny P, Lepage E, Brousse N et al. Doxorubicin-containing regimen with or without interferon alpha-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 trial. J Clin Oncol 1998; 16: 2332-2338.
5. Hiddemann W, Unterhalt M., Wandt H et al. Myeloablative radiochemotherapy followed by blood-stem cell-transplantation significantly prolongs the disease-free interval in patients with low-grade lymphomas as compared to standard maintenance with interferon alpha: results of a prospective randomized comparison by the German Low Grade Lymphoma Study Group (GLSG). Blood 1998; 94 (Suppl 1): 610a (Abstr 2715).